Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
US5399573A · kind A · utility
4Cited by
9References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 1992 |
| Grant date | Mar 21, 1995 |
| Priority date | — |
| Expiry date | Sep 1, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula: ##STR1## are useful for treatment of cataracts in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.